Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

Niamh McGivern, Aya El-Helali, Paul Mullan, Iain A McNeish, D Paul Harkin, Richard D Kennedy, Nuala McCabe

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)
252 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science